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Age-related accumulation of Reelin in amyloid-like deposits
Abstract
Accumulating evidence suggest that alterations in Reelin-mediated signaling may contribute to neuronal
dysfunction associated with Alzheimer's disease (AD), the most common form of senile dementia.
However, limited information is available on the effect of age, the major risk factor of AD, on Reelin
expression. Here, we report that normal aging in rodents and primates is accompanied by accumulation
of Reelin-enriched proteinous aggregates in the hippocampal formation that are related to the loss of
Reelin-expressing neurons. Both phenomena are associated with age-related memory impairments in
wild-type mice. We provide evidence that normal aging involves loss of Reelin neurons, reduced
production and elimination of the extracellular deposits, whereas a prenatal immune challenge or the
expression of AD-causing gene products, result in earlier, higher, and more persistent levels of
Reelin-positive deposits. These aggregates co-localize with non-fibrillary amyloid-plaques, potentially
representing oligomeric Abeta species. Our findings suggest that elevated Reelin plaque load creates a
precursor condition for senile plaque deposition and may represent a critical risk factor for sporadic AD.
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ABSTRACT 
Accumulating evidence suggest that alterations in Reelin-mediated signalling may contribute 
to neuronal dysfunction associated with Alzheimer’s disease (AD), the most common form of 
senile dementia. However, limited information is available on the effect of age, the major risk 
factor of AD, on Reelin expression. Here, we report that normal aging in rodents and primates 
is accompanied by accumulation of Reelin-enriched proteinous aggregates in the hippocampal 
formation that are related to the loss of Reelin-expressing neurons. Both phenomena are 
associated with age-related memory impairments in wild-type mice. We provide evidence that 
normal aging involves loss of Reelin neurons, reduced production and elimination of the 
extracellular deposits, whereas a prenatal immune challenge or the expression of AD-causing 
gene products, result in earlier, higher, and more persistent levels of Reelin-positive deposits. 
These aggregates co-localize with non-fibrillary amyloid-plaques, potentially representing 
oligomeric Aβ species. Our findings suggest that elevated Reelin plaque load creates a 
precursor condition for senile plaque deposition and may represent a critical risk factor for 
sporadic AD.  
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1. INTRODUCTION 
Reelin is a large extracellular glycoprotein secreted by Cajal-Retzius cells and mediating 
proper positioning of neurons during development through the activation of the 
apolipoprotein E receptor 2 (ApoER2) and very-low-density lipoprotein receptor (VLDLR, 
(D'Arcangelo et al., 1995, 1999; Hiesberger et al., 1999; Howell et al., 1997; Tommsdorff et 
al., 1999). Transduction of the signal involves the interaction of the adapter protein Dab1 with 
the intracellular NPxY motiv of these receptors, resulting in tyrosine phosphorylation of 
Dab1, activation of Src family of non-receptor tyrosine kinases, and triggering a downstream 
cytosolic kinase cascade beginning with the activation of phosphatidylinositol-3-kinase 
(PI3K) and ending with the inhibition of glycogen synthase kinase 3β (GSK3β; for recent 
review, see Herz and Cheng, 2006). The signal is terminated with Reelin targeted to the 
lysosome and Dab1 degraded by the proteasome (Arnaud et al., 2003; Bock et al., 2004; 
Morimura et al., 2005). In the adult brain, Reelin expression is maintained by GABAergic 
interneurons and glutamatergic pyramidal neurons in layer II of the entorhinal cortex 
(Alcantara et al., 1998; Miettinen et al., 2005; Pesold et al., 1998; Ramos-Moreno et al., 2006) 
and the same signalling cascade is used in adult synapses to modulate neuronal function and 
synaptic plasticity by regulating glutamate receptor activity through the phosphorylation of 
intracellular tyrosine residues (Beffert et al., 2005, 2006; Chen et al., 2005; Weeber et al., 
2002). 
In line with its critical role in synaptic transmission and learning and memory, several 
recent findings suggest that alterations in Reelin signaling may contribute to neuronal 
dysfunction associated with Alzheimer’s disease (AD). This most common type of dementia 
is characterized by progressive cognitive decline and two histopathological hallmarks 
including amyloid-beta (Αβ) plaques, which are caused by an imbalance in Aβ metabolism, 
and neurofibrillary tangles that result from abnormal phosphorylation and aggregation of Tau 
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(Glenner and Wong, 1984; Grundke-Iqbal et al., 1986). Reelin binding to its receptors 
potently downregulates the activity of GSK3β, a major Tau kinase, and as a result mutant 
mice with defects in the Reelin signaling show increased levels of hyperphosphorylated Tau 
(Beffert et al., 2004; Hiesberger et al., 1999; Ohkubo et al., 2003). In addition, the Reelin 
receptors are also targets of the common ApoE isoform ε4, a major genetic risk factor 
associated with sporadic AD (Corder et al., 1993; Schmechel et al., 1993). The finding that 
recombinant ApoE ε3 and ε4 inhibit Reelin binding by 50 – 60% (D'Arcangelo et al., 1999) 
indicates that lipid-associated ApoE could compete with Reelin for lipoprotein receptor 
activation. As a consequence, impaired ApoE receptor signaling may result in a dysbalance in 
cholesterol homeostasis, which has been shown to profoundly affect the production and 
trafficking of Aβ (Simons et al., 1998) and hypothesized to underlie accelerating synaptic loss 
and onset of dementia (Herz and Chen, 2006; Raber et al., 1998; Weeber et al., 2002). Further 
support for a direct link between Reelin and amyloid precursor protein (APP) processing has 
recently been proved by Hoe and colleagues by demonstrating that Reelin increases the 
intracellular interaction of Dab1 with ApoER2 and APP and promotes their cleavage, 
resulting in reduced toxic Aβ production (Hoe et al., 2006a). Moreover, recent data from AD 
patients reporting altered Reelin expression levels in both CSF and cortical tissue (Botella-
Lopez et al., 2006; Saez-Valero et al., 2003) point to profound alterations in Reelin processing 
and signaling potentially underlying AD-related neuronal dysfunction. Although Reelin, 
ApoE receptors, and APP functionally converge at synaptic sites likely joining forces to 
control glutamate receptor activity and regulate neurotransmission, cognition and memory, it 
is currently unknown whether Reelin expression is affected by age; the major risk factor of 
AD. We therefore set out a comprehensive investigation on Reelin expression in different 
species during normal and pathological forms of aging. 
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2. METHODS AND MATERIALS 
Animals. All procedures were approved by the local authorities and were performed in 
accordance with the European Community Council Directive of 24 November 1986 
(86/609/EEC). Six different groups of animals were employed (Table 1). Group1: Adult (4 – 
5 mo), middle-aged (11-14 mo), and old (20-23 mo) wild-type mice were obtained from 
Janvier (France) and caged in groups of 4 – 5 in a climatized animal-keeping room maintained 
under a 12-h reversed light-dark cycle and ad lib food and water (University of Bordeaux 1, 
France). For the behavioral tests, the animals were single caged and introduced to a 
progressive food deprivation and maintained at about 90% of their free feeding weight 
throughout the experiments. Group 2: Synaptic Ras-GTPase activating protein, SynGAP+/+ 
and SynGAP+/- mice were obtained from heterozygous breeding pairs, genotyped as described 
(Vazquez et al., 2004) at the age of 3 weeks and housed in same sex groups of 4 to 5 in a 
specified pathogen free (SPF) animal facility (ETH Zurich, Schwerzenbach, Switzerland) 
under 12-h reversed light-dark cycle and ad lib food and water. Group3: Offspring born to 
PolyIC- (5 mg/kg, injected at gestational day 9 or 17) or vehicle-treated mothers were weaned 
and sexed at 3 weeks and housed at the ETH Zurich as described (Meyer et al., 2006). 
Group4: The offspring of triple transgenic Alzheimer’s mice harboring two transgenes 
(encoding APPSwe, and tauP301L) on a homozygous PS1M146V knock-in background (Oddo et 
al., 2003) and the non-transgenic control mice were housed in groups of 4-5 in the SPF 
facility as described above. Confirmation of the genotypes was done with postmortem tail 
biopsies as described (Oddo et al., 2003). Groups 5/6: The housing conditions for rats and 
common marmoset monkeys were as described (Nyffeler et al., 2007; Pryce et al., 2005). 
 
Behavioral testing. The construction and dimension of the eight-arm radial arm maze (RAM) 
have been described in detail elsewhere (Marighetto et al., 1999). The task consisted of 
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concurrent serial alternations assessing episodic-like memory performance. Each subject was 
individually assigned six adjacent arms which were grouped into three pairs (A, B, C), each 
consisting of a baited and unbaited arm. For each pair, the location of the food reward 
alternated between successive trials. A total of 14 daily sessions were performed (2 for 
habituation and 12 for memory tests). Each memory test session consisted of 23 trials: 3 
acquisition trials for each pair (with both arms rewarded), followed by 20 memory test trials 
(Fig. 1 A). On each trial, two adjacent arms were opened simultaneously. A choice was 
considered to be made when the subject had reached the food located at the end of the arm; 
this also triggered the closure of the door to the alternative arm. After the subject returned to 
the central platform, the door was closed and the trial ended. Subjects were confined to the 
centre during a 10 s inter-trial interval. The level of difficulty of a given trial depended on the 
number of interposed trials, resulting in retention intervals ranging from 0 to 4 (Fig. 1 A). The 
percentage of correct choices was recorded for each session and averaged by blocks of three 
consecutive days or by trials of the same level of retention interval. 
 
Immunohistochemistry. Animals were deeply anesthetized with an overdose of sodium 
pentobarbital and perfused through the ascending aorta with a fixative containing 4% 
paraformaldehyde in 0.15 M phosphate buffer, pH 7.4. After postfixation in the same fixative 
overnight, the brains were cryoprotected in 30% sucrose, frozen, and stored at -80°C (groups 
1, 5, 6). Mice of groups 2 – 4 were perfused with the above fixative containing 15% picric 
acid. These brains were processed for antigen-retrieval immunohistochemistry as described 
(Fritschy et al., 1998). For all groups, free-floating sections (40 - 50 µm thick) were cut 
coronally on a sliding microtome. Random sampled serial sections were collected throughout 
the hippocampal formation and stored at -20°C in cryoprotectant solution until further 
processing. Sections were incubated overnight at room temperature (immunoperoxidase; IP) 
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or 4°C (immunofluorescence, IF) in the primary antibody solutions (Table 2) diluted in PBS 
containing 2% normal goat serum and 0.3% Triton X-100. Sections were then washed 3 times 
with PBS. For the IP stainings, a 1 h incubation in biotinylated secondary antibodies (Jackson 
ImmunoResearch Laboratories Inc., West Grove, PA) diluted 1:500 in PBS was performed at 
room temperature, followed by three rinses in PBS, incubation with Vectastain Kit (Vector 
Laboratories; Burlingame, CA) and the 3,3-diaminobenzidine (DAB; Sigma-Aldrich Inc, St. 
Louis, MO) staining for 5 – 10 min as described (Meyer et al., 2006; Nyffeler et al., 2007; 
Pryce et al., 2005). Counterstaining of Reelin-IP labeling was done with 0.25% Cresyl violet 
according to standard protocols. For double- or triple IF, sections were incubated for 30 min 
at room temperature in corresponding secondary antibodies coupled to Alexa488 (Molecular 
Probes, Eugene, OR), Cy3 or Cy5 (Jackson ImmunoResearch Laboratories), washed again, 
mounted on gelatinized glass slides, air dried, and coverslipped with FluorSave™ 
(Calbiochem, San Diego, CA) mounting medium. Control stainings included the incubation of 
the sections with 1 μg/ml mouse or rabbit IgG (Jackson ImmunoResearch), rabbit pre-
immune serum (diluted at 1:500), or the secondary goat-anti mouse or rabbit antibody 
(coupled to HRP, Alexa488, or Cy3; diluted 1:500) alone. For the nuclear labeling, sections 
were incubated for 5 min in 10 nM SYTOX green nucleic acid stain (Invitrogen, Carlsbad, 
CA) dissolved in PBS.  
 
Data Analysis. All quantitative analyses were done on one randomly selected hemisphere and 
performed blind to the age, genotype, or treatment classification of the animals. IP stainings 
were analyzed with bright-field microscopy and digital images acquired using a color digital 
camera (AxioCam, Zeiss, Germany) controlled by AxioVision 4.1 software (Zeiss). Exposure 
times were set so that pixel brightness was never saturated, and were held constant during 
acquisition of all images for each experiment. IF double- and triple labelings were visualized 
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by confocal microscopy (LSM-510 Meta, Zeiss) using a 40x (NA 1.3) or 100x objective (NA 
1.4) and sequential acquisition of separate channels. The pinhole aperture was set to 1.0 Airy 
unit for each channel. Stacks of consecutive optical sections (6 – 12; 512 x 512 pixel, spaced 
1 μm in z) were acquired at a magnification of 0.11 - 0.22 μm/pixel. For visual display, Z-
sections of both channels were summed and projected in the z dimension (maximal intensity) 
and merged using the image analysis software Imaris (Bitplane, Zurich, Switzerland). 
Cropping of images, adjustments of brightness and contrast were identical for each labeling 
and done using Adobe Photoshop (Adobe Systems, San Jose, CA). 
 Volume analysis and quantification of Reelin plaques (groups 1 – 4): Volumetric analysis of 
the hippocampus was performed with StereoInvestigator software (version 6.50.1, 
Microbrightfield, Colchester, VT). Every section per series was measured providing an 
average of 7 to 9 sections per animal. The subfield areas were delineated with a 2.5x objective 
(NA 0.075). The volumes were estimated according to the formula V = ∑A × tnom × 1/ssf, 
where ∑A = the summed areas of the delineated subfields (CA, DG, hilus; separately for 
dorsal and ventral hippocampus), tnom = the nominal section thickness of 40 (groups 2 – 4) or 
50 µm (group 1), and ssf = the section sampling fraction (1/4, group 1; 1/9, group 3; 1/8 
groups 2, 4). Plaques were counted exhaustively within the delineated hippocampus using a 
marker tool of StereoInvestigator. For the analysis, the total number of plaques was included; 
estimated for the dorsal and ventral hippocampus separately according to the formula Ptot = 
∑P × 1/ssf, where ∑P = the sum of plaques, as well as the total number of plaques per unit 
volume (Ptot /voldhip or vhip (mm3).  
Stereological estimation of Reelin neurons (groups 1 - 3): The total number of Reelin neurons 
was determined along the whole septo-temporal axis of the hippocampus on high 
magnification images composed using Mosaic™ software (Explora Nova, Universal 
Laboratory Imaging, LaRochelle, France). The same sections as described above (starting at 
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the beginning of the hippocampal formation) were included. Cell counts were done in CA 
(including so, sr, slm) and DG (ml) using NIH ImageJ software by applying a threshold to 
include only immunolabeled cells in the analysis. A mask of the cells in the CA or DG, 
respectively, was created by outlining the corresponding area and excluding particles smaller 
than 80 and larger than 500 pixels2. For the analysis, the total number of cells was included, 
estimated again for the dorsal and ventral hippocampus separately according to the formula 
Ctot = ∑C × 1/ssf, where ∑C = the sum of cells, as well as the total number of cells per unit 
volume (Ctot /voldhip or vhip (mm3).  
 
Statistical analysis. Data were analyzed using analysis of variance (ANOVA) with the 
statistical software StatView version 5.0 (Abacus Concepts, Inc., Berkeley, CA). Fisher’s 
LSD post hoc comparisons were performed whenever appropriate. Age (3 levels), Genotype 
(controls, mutants), and Treatment (PolyIC, vehicle), were the main between-subjects factors, 
while Axis (dorsal, ventral), Subfields (CA, DG), Blocks of behavioral training sessions (4 
levels), and Retention Interval (five levels) were included as main within-subjects factor. The 
factor Sex (groups 2 and 3) was dropped to enhance statistical power since it did not yield a 
significant outcome. Pearson's product moment correlations were performed between the 
immunohistochemical variable (ratio cells/plaque) and the behavioral measures (mean 
performance in the RAM) using StatView. Statistical significance was set at p < 0.05. 
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3. RESULTS 
Age-related episodic-like memory deficits are paralleled by accumulation of Reelin 
plaques in the hippocampal formation of wild-type mice.  
Epidemiological evidence suggests that prodromal impairments in multiple cognitive domains 
including executive functioning, episodic memory and perceptual speed occur several years 
before AD diagnosis (Collie and Maruff, 2000). Qualitatively, these impairments are not 
different from the cognitive impairments observed during normal aging, suggesting continuity 
rather than discontinuity from normal senescence to preclinical AD (Backman et al., 2004). 
Similarly, structural and functional alterations of the hippocampal formation which is 
critically involved in the encoding, storage and retrieval of episodic memory occur during 
normal human aging and are evident long before the diagnosis of AD (Small et al., 2000). 
Here, we used the radial arm maze to assess potential episodic-like memory deficits in normal 
aged wild-type mice using a “concurrent serial alternations” task (Mingaud et al., 2005; 
Mormede et al., 2006). Three groups of mice were employed: adults (ad, 4-5 months), 
middle-aged (ma, 11-14 months), and old (20-23 months, Table 1). The location of the food 
reward on a pair of presented adjacent arms varied according to an alternation rule between 
successive trials (Fig. 1 A). The mouse had to remember which of the two arms of a given 
pair had been visited in a particular trial until the next presentation of this pair in order to 
alternate its choices among successive presentations. The retention interval (RI) ranged from 
0 – 4 (Fig 1A), depending on the number of trials interposed between two successive 
presentations of the same pair. Animals were tested for 12 consecutive days starting with 3 
acquisition trials, followed by 20 test trials per day. The performance, expressed as % correct 
choices, significantly increased across training days in ad subjects and to a lesser extent in ma 
and old mice (Fig. 1 B left). The overall performance was significantly better in ad (72.0 ± 
2.1%) than in ma (62.2 ± 4.2%; p = 0.04) and old (61.7 ± 1.8%; p = 0.02, Fig. 1 B middle) 
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mice. When the performance was averaged by trials of the same RI, the analysis revealed that 
the percentage of correct responses decreased with increasing RI in all groups (Fig. 1 B right). 
The ma and old subjects displayed normal immediate memory (RI = 0) but very poor 
retention of previous events as soon as RI was increased by one or two interposed trials, 
indicating that the aged mice exhibited a selective and specific deficit of memory for recent 
episodes.  
In view of the role of Reelin and its receptor ApoER2 in modulating LTP and learning 
(Beffert et al., 2005; Qiu et al., 2006; Weeber et al., 2002), we determined whether the 
memory impairments in aged wild-type mice were accompanied by alterations in localization 
and distribution of Reelin neurons in the hippocampal formation (Table 1). Reelin-
immunoreactivity (IR) was detected in both the neuropil and interneuron somata throughout 
the forebrain (Fig. 1 C-K), as reported in adult and aged wild-type mice (Miettinen et al., 
2005; Ramos-Moreno et al., 2006). Representative pictures of ad, ma and old mice show the 
pattern of Reelin neurons in the hippocampal formation, predominantly localized in CA 
stratum oriens (so), radiatum (sr), lacunosum-moleculare (slm), DG molecular layer (ml), 
hilus, and layer I and II of the entorhinal cortex. A prominent somatic labeling was also 
evident in all layers of the neocortical areas. The neuropil staining was clearly differentiated 
from the background (i.e. corpus callosum) and was especially prominent in the ventral slm of 
ad subjects. Although the distribution of Reelin-positive cells did not change during aging, a 
reduction of the number of these cells in so, slm, and ml was evident, particularly in the 
ventral hippocampus (Fig. 1 H).  
A major feature not seen in ad subjects were the Reelin-positive plaque-like aggregates in 
the neuropil of ma and old mice, highly restricted to distinct layers of the hippocampal 
formation including the dorsal subiculum, CA so, sr, and ventral CA slm and outer ml of the 
DG (arrows in Fig. 1 D, E, H). In addition, layer I of the entorhinal and piriform cortex 
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contained Reelin plaques. Except for a few single deposits in the somatosensory cortex and 
caudate putamen in old subjects, no other brain region examined contained these deposits. In 
order to rule out that these aggregates simply reflect non-specific antibody labeling, we 
performed a series of control stainings of the same brain sections using mouse or rabbit IgG, 
rabbit pre-immune serum, or the secondary antibodies alone (Supplementary Fig. 1). None of 
these stainings produced any immunoperoxidase reactivity on the extracellular aggregates.  
With immunofluorescent secondary antibodies, only the intracellular age-pigment lipofuscin 
was non-selectively labeled by the secondary antibodies (data not shown). These data confirm 
that the Reelin-IR in extracellular deposits is not a staining artifact but show that Reelin is 
specifically localized to these aging-related aggregates. Closer examinations of these 
accumulations revealed a tight association with Reelin-expressing neurons and a granular 
rather than fibrillary appearance at one year of age (Fig. 1 K). Similar appearances albeit often 
associated with a more diffuse and irregular shape was evident in two years old wild type 
mice (Fig. 1 L). These results suggest that Reelin accumulates in amyloid-like aggregates 
specifically in the hippocampal formation of aged wild-type mice. 
 
Neuronal loss and increase in plaque load both contribute to the memory deficits 
observed in wild-type mice.  
We quantified the number of both Reelin neurons and plaques in the dorsal and ventral 
hippocampus obtained from the behaviorally tested animals by stereology. The statistical 
analysis confirmed the profound loss of Reelin-expressing neurons in the old compared to ma 
and ad subjects (p < 0.01). Separate comparisons for the subregions yielded significant group 
differences for the dorsal (ad vs old, ma vs old: p < 0.05) and ventral hippocampus (ad vs old, 
ma vs old: p < 0.01; Fig. 2 A). Similarly, statistical evaluations of the plaques yielded 
significant differences between ad and ma mice for both the dorsal and ventral parts (all p < 
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0.01) but not between ad and old subjects (all p > 0.05, Fig. 2 B), reflecting reduced 
production and elimination of plaques in a subgroup of old subjects. However, a few old mice 
were characterized by a marked increased plaque load (outlier in Fig. 8 A), suggesting that 
these individuals fail to remove the protein aggregates. By expressing the two variables as a 
ratio, cells/plaques, we obtained significant reductions in ma compared to ad mice in the 
dorsal (p < 0.05) and between both aged groups compared to ad in the ventral hippocampus 
(all p < 0.01, Fig. 2 C), supporting the view that the combination of cell loss and plaque 
accumulation may account for age-related hippocampal memory impairments. This 
hypothesis was supported by the correlational analysis between the ratio of cells/plaques and 
the mean performance on the RAM revealing a significant positive relationship (df = 31, r = 
0.46, p = 0.006). A similar significant relationship was evident when comparing the ratio of 
cells/plaques and the mean performance focusing on RI 1 and 2 (Fig. 2 D, df = 31, r = 0.499, 
p = 0.003). Correlational analysis of the three age groups separately yielded a statistical 
significant relationship for ma (df = 8, r = 0.66, p = 0.03) and old (df 14, = r = 0.63, p = 
0.007), but not for the ad subjects (df = 5, r = 0.09, p = 0.86). However, two individual 
outliers were responsible for the significant correlation (Fig. 2 E). This is reminiscent of the 
variability in cognitive decline among elderly subjects and confirms that cognitive aging is 
not strictly linked to chronological age. Indeed, removing these two outliers from the analysis 
did not change the overall correlation (df = 29, r = 0.444, p = 0.011), indicating that the 
morphological deficit may indeed represent a good predictor of the cognitive performance in 
adulthood.  
 
Reelin plaques are extracellular deposits invaded by activated microglia and astrocytes.  
Degenerating tissue and deposition of insoluble protein aggregates are stimulants of 
inflammatory responses. To determine whether Reelin plaques are associated with activated 
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microglia and reactive astrocytes, we performed triple-fluorescence labeling using GFAP and 
F4/80 as markers for astrocytes and activated microglia, respectively, in combination with 
Reelin-antibodies and the nuclear dye Sytox green on brain sections of ma behaviorally naïve 
wild-type mice (Fig. 3 A-H). We found a local increase in both GFAP and F4/80-IR in layers 
with high plaque load, particularly prominent in slm. The astrocytic processes closely 
surrounded but did not co-localize with the plaques (Fig. 3 D). Activated microglia were 
found in high densities around and within the plaques, as indicated by the co-localization of 
Reelin and F4/80 (Fig. 3 H, arrowheads). Moreover, microglia co-localized with Reelin in 
degenerating neurons, as shown by the presence of condensed and shrunken Sytox green-
positive nuclei (Fig. 3 E-H, arrows). The inset in H shows an enlarged view of a degenerating 
cell within a Reelin-positive plaque. These results confirm the extracellular localization of 
these plaques and further suggest that their presence triggers a local neuroinflammatory 
response that might contribute to the elimination of these proteinous deposits in old wild-type 
mice. 
Reelin, via its interaction with ApoER2 and subsequent association of Dab1 and Fe65, 
modulates APP processing and secretion of Aβ peptides in neuronal cell cultures (Hoe et al., 
2006a,b). Here, we tested whether the expression of these proteins are affected by the 
reduction of Reelin. Double-fluorescent labelling on hippocampal brain sections of ma wild-
type mice showed that Reelin plaques (Fig. 3 I) differed in terms of the size of individual 
aggregates. ApoER2, which showed a strong clustered IR throughout the hippocampal 
formation (Fig. 3 J-L), was particularly enriched around smaller, potentially developing 
aggregates (Fig. 3, inset in K is enlarged in L) and formed there larger clusters compared to 
the plaque-free neuropil. The bigger Reelin-positive aggregates were not co-stained for 
ApoER2. ApoER2-IR was much weaker in neocortical and other brain areas as compared to 
the hippocampus (data not shown). Both Dab1 and Fe65 were highly enriched in large Reelin 
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plaques throughout the hippocampal formation (Fig. 3 M–P). These results indicate that 
altered levels of Reelin are associated with the accumulation of signaling proteins involved in 
APP trafficking and processing. 
 
Reelin plaques are found in aged Wistar rats and common marmoset monkeys.   
To determine whether the pronounced accumulation of Reelin plaques accompanying 
neuronal loss was a phenomenon unique to mice or a more general morphological 
characteristic of normal aging, we performed a qualitative evaluation of rat and monkey brain 
tissue obtained from adult and aged subjects processed for Reelin immunohistochemistry 
(Fig. 4). A similar Reelin-IR was evident in rat tissue as described in mice and was restricted 
to interneurons in so, sr, and slm, as well as DG gcl, ml, and hilus (Fig. 4 A). We did not 
detect Reelin plaques in 6-mo old rats but the dorsal and ventral hippocampus of two-year old 
subjects contained Reelin-positive aggregates in the neuropil of so, sr, and slm (high 
magnification in Fig. 4 D). However, at 2 years of age the ventral slm did not contain 
numerous plaques but was characterized by strikingly low numbers of Reelin-expressing 
neurons, suggesting a pronounced age-related loss of GABAergic cells (Fig. 4 B, arrows). In 
addition, many Reelin neurons with dystrophic neurites were found (Fig. 4 C). A similar 
Reelin-IR pattern as described in rodents was evident in the 1- and 10-year old monkey 
hippocampus. Although the intensity of Reelin-IR in neuronal soma was much weaker 
compared to rodent tissue (Fig. 4 F, H), Reelin plaques were clearly identifiable in sr and slm 
of the hippocampus of both the 1- and 10-year old monkey (arrows in F). Higher 
magnification revealed intracellular aggregates of Reelin throughout the hippocampal 
formation (Fig. 4 G) but not in cortical or non-cortical brain areas (data not shown). These 
results suggest that Reelin plaques represent a general morphological phenomenon, related to 
the loss of Reelin-expressing interneurons in the hippocampal formation during normal aging.  
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Heterozygous SynGAP knockout mice have less Reelin neurons and develop fewer 
plaques.  
To directly test the hypothesis of a predictive relationship between Reelin-expressing neurons 
and plaques, we investigated in mice with neurodevelopmental abnormalities whether an early 
loss of GABAergic interneurons affects the development of Reelin plaques during aging. We 
employed a cohort of SynGAP (synaptic Ras-GTPase activating protein) heterozygous 
knockout (SG+/-) mice and their littermate wild-type controls (SG+/+) at the age of 3 (ad), 6 
and 12 (ma), and 24 months (old). The complete loss of the synaptic Ras/Rap inhibitor 
SynGAP leads to early apoptotic loss of GABAergic neurons and death 2 to 3 days after birth 
(Knuesel et al., 2005). Here, we investigated whether neuronal loss was also evident in adult 
SG+/- mice and affected the Reelin-expressing class of GABAergic interneurons. The 
stereological estimates of Reelin neurons in the dorsal and ventral hippocampus of ad, ma, 
and old SG+/+ and SG+/- mice revealed that SG+/- mice had significantly less Reelin-expressing 
cells in the hippocampus than SG+/+ (p = 0.003), regardless of age (ad, p = 0.05; ma, p = 
0.007; old, p = 0.03, Fig. 5 B). The effect was particularly prominent in CA so and slm (Fig. 5 
A,C) and affected the ventral subfield more than the dorsal. Double-immunofluorescence 
staining using Reelin and SynGAP antibodies on old SG+/+ hippocampal brain sections 
confirmed the co-localization of these two proteins in both healthy (Fig. 5 D-F, arrows) as 
well as degenerating GABAergic interneurons (arrowheads). Evaluation of Reelin plaques in 
this cohort of mice (Fig. 5 G-K) revealed significantly lower levels in the ventral 
hippocampus of 12-mo old SG+/- compared to age-matched controls (p < 0.05), whereas the 
difference in the dorsal subfields did not reach statistical significance (Fig 5 I). The number of 
Reelin plaques was not different between genotypes in either 24-mo old or less than 6-mo old 
mice (Fig. 5 L), indicating that the lower plaque load in 12-mo old mice was not due to an 
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earlier and faster accumulation of extracellular aggregates but related to the reduced number 
of Reelin neurons in SG+/- mice.  
 
Prenatal immune challenge results in earlier accumulations of Reelin plaques and loss of 
Reelin neurons  
To determine whether a prenatal immune challenge leading to cytokine-associated fetal brain 
inflammation (Meyer et al., 2006) and changes in the expression levels of several immune 
modulators in adulthood (Meyer, Nyffeler, Yee, Feldon, Knuesel, unpublished data) exerts 
long-term consequences on the development of Reelin plaques, we evaluated the plaque-load 
using Reelin immunohistochemistry in adult wild-type mice prenatally exposed to either 
vehicle (CON) or the synthetic viral mimic polyriboinosinic-polyribocytidilic acid (PolyIC; 
Meyer et al., 2005, 2006). In line with our previous observations, CON subjects had only few 
plaques at 6-mo of age (Fig. 6 A). In contrast, the hippocampus and entorhinal cortex of 
PolyIC-exposed mice contained greater numbers of Reelin plaques, again most prominent in 
the ventral CA so, sr, slm, and DG ml (Fig. 6 B, D), as well as layer I of the lateral entorhinal 
cortex. Cresyl violet counterstainings confirmed that the Reelin plaques were extracellular 
(data not shown) as described in wild-type subjects. In line with the previous observations in 
mice and rats, the increase in plaques was accompanied by a loss of Reelin neurons in CA so, 
slm, and DG ml, as shown by unbiased stereological quantification. Statistical analyses of the 
number of Reelin neurons yielded significant differences between the CA and DG areas, 
irrespective of the septo-temporal axis (Fig. 6 E, p < 0.05). The number of plaques was 
significantly increased in both dorsal and ventral hippocampus in PolyIC compared to CON 
subjects (p < 0.05). Correspondingly, the ratio between Reelin-positive cells and plaques 
combined for the whole hippocampus dropped significantly in PolyIC subjects compared to 
CON (p = 0.015), similar to the comparison between ma and old wild-type mice (Fig. 2 C). 
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These results indicate that a prenatal immune challenge accelerates the loss of Reelin neurons 
and the accumulation of Reelin aggregates in the hippocampal formation of adult wild type 
mice. 
 
Reelin plaques are highly increased in AD mice and co-localize with non-fibrillary 
species of amyloid-beta.  
Reelin-IR has been detected in plaques of APP/PS1 double-transgenic AD mice (Wirths et al., 
2001) and linked to APP processing and Aβ production (Hoe et al., 2006a). In view of the 
prominent accumulations of protofibrillary Aβ plaques in 12-mo old triple transgenic AD 
mice (3xTg-AD, Oddo et al., 2003), we evaluated whether Reelin co-localizes with Aβ 
plaques in this animal model of AD. We investigated brain tissue obtained from 15-mo old 
non-transgenic control (CON) and 3xTg-AD mice. In CON, a comparable accumulation 
pattern and load of plaques as in age-matched C57Bl6 wild-type mice was evident. In 
contrast, 3xTg-AD mice showed a pronounced increase in Reelin plaques, especially in the 
dorsal and ventral CA sr and slm (Fig. 7 A-B). The statistical analysis yielded a significant 
genotype effect (p < 0.01) and confirmed again the more pronounced effect in ventral (p < 
0.01) as compared with the dorsal hippocampus (p = 0.052, Fig. 7 M) in 3xTg-AD. To 
examine whether the Reelin plaques co-localized with β-amyloid plaques in 3xTg-AD, we 
performed double-IF staining using antibodies against Reelin and human Aβ. We confirmed 
the presence of the characteristic fibrillary Aβ plaques as described (Oddo et al., 2003; Fig. 7 
D, arrow). Human Aβ-IR was present in Reelin-expressing neurons, but no co-localization of 
the two markers was found in fibrillary plaques (Fig. 7 C-E). However, some Aβ-IR was 
present in non-fibrillary plaques, largely co-localizing with Reelin-IR (Fig. 7 F-H). Double-IF 
using antibodies against Reelin and Aβ oligomer species (A11, Kayed et al., 2003) revealed a 
highly similar IR pattern, suggesting that plaques positive for human Aβ  and Reelin represent 
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soluble, non-fibrillary amyloid deposits (Fig. 7 I). While we observed an almost complete 
overlap between Reelin- and Aβ oligomer-IR, single-labeled Aβ-containing oligomeric 
species were detected outside the hippocampal formation (Fig. 7 L), confirming the 
specificity of the antibody stainings. To determine whether Reelin is also localized in 
endogenous Aβ aggregates, we next stained the sections with antibodies against the rodent β-
amyloid and Reelin (Fig. 7 J). Rodent-specific Aβ-IR was localized in fibrillary amyloid 
deposits, closely associated with the Reelin deposits (arrow in J) in 3xTg-AD mice. Due to 
the high sequence similarity and potential cross-reactivity between the rodent and human-
specific Aβ antibodies, we also stained control sections of wild type littermates. We observed 
a selective association and partial co-localization between Reelin and Aβ-positive aggregates 
in the hippocampus of control mice (Fig. 6 K). These data suggest that the accumulation of 
Reelin in non-fibrillary plaques may promote the aggregation of Aβ species; potentially 
creating a nucleation site for fibrillary amloid Aβ plaques. 
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4. DISCUSSION 
We report the novel finding that normal aging in rodents and primates is accompanied by 
accumulations of Reelin-positive deposits and reduction of Reelin-expressing neurons in the 
hippocampal formation. Both phenomena are associated with episodic-like memory 
impairments. We provide evidence that normal aging involves loss of Reelin-positive 
neurons, reduced production, and elimination of the extracellular deposits, whereas prenatal 
brain inflammation or the expression of AD-causing gene products results in earlier, higher, 
and more persistent levels of Reelin aggregates, potentially contributing to progressive 
cognitive decline (Fig. 8).  
The distribution of Reelin-IR described here (Fig. 1, 4) is in accordance with previous 
studies, revealing its expression in GABAergic interneurons, adult Cajal-Retzius cells, and 
pyramidal cells in layer II of the entorhinal cortex in rodents and humans (Abraham and 
Meyer, 2003; Alcantara et al., 1998; Miettinen et al., 2005; Ramos-Moreno et al., 2006; 
Riedel et al., 2003). The prominent loss of Reelin neurons in CA so, slm and DG ml is in line 
with reductions in the GABAergic markers GAD67, Calbindin, and Somatostatin in the aged 
rat hippocampus (Potier et al., 1994; Shetty and Turner, 1998), and Somatostatin/NPY in 
APP/PS1 transgenic mice (Ramos et al., 2006). Subfield- and layer-specific reductions have 
been reported for Parvalbumin, Calretinin, and Calbindin, as well as a moderate (Riedel et al., 
2003) to severe loss of Reelin-positive Cajal-Retzius cells (Baloyannis, 2005) and layer II 
pyramidal cells in the AD entorhinal cortex (Chin et al., 2007).  
Hippocampal GABAergic interneurons represent only ~10% of the total hippocampal 
population, but their extensively ramified axons innervate several thousand pyramidal cells, 
thereby playing a major role in synchronization of neuronal activity and network oscillations 
(Freund and Buzsaki, 1996). They are also the target of several subcortical neurotransmitter 
systems, including septal GABAergic and cholinergic, as well as monoaminergic projections 
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from brainstem areas. Although the cholinergic components contact all neuronal types in the 
hippocampus, the GABAergic septohippocampal fibers terminate on interneurons exclusively 
(Freund and Buzsaki, 1996). A loss of Reelin cells in hippocampal subfields is expected to 
profoundly affect the afferent subcortical systems and alter hippocampal activity and function. 
A deficit in cholinergic neurotransmission may underlie the episodic-like memory 
impairments reported here (Fig. 1), in line with the reduction of cholinergic activity 
accompanying normal aging and AD (Sarter and Bruno, 2004). Complementary glutamatergic 
changes are likely involved in age-related memory impairments, potentially via reduced 
Reelin-mediated modulation of NMDA receptor activity and LTP (Beffert et al., 2005; Chen 
et al., 2005; Weeber et al., 2002). It is conceivable that age-related reductions of Reelin 
indirectly affect cognitive performances by favoring the production of soluble Aβ species, 
shown to impair LTP (Rowan et al., 2005; Walsh et al., 2002; Wang et al., 2002).  
 To the best of our knowledge, no data are available on the existence of Reelin-positive 
accumulations in the hippocampal formation of wild-type mice, rats, non-human primates or 
humans. Three studies described Reelin- and ApoER2-IR, respectively, in neuritic 
compartments of Aβ plaques in transgenic AD mice (Miettinen et al., 2005; Motoi et al., 
2004; Wirths et al., 2001). It is unclear, however, whether they were associated with non-
fibrillary or fibrillary plaques. On the other hand, our observations fit very well with early 
histological descriptions of age-associated morphological and pathological changes in rodent 
brains reporting the presence of granular/fibrillary deposits in the hippocampus of aged 
C57Bl/6, as well as in adult immunologially deficient athymic nude and senescence 
accelerated prone mice (Akiyama et al., 1986; Jucker et al., 1994a; Lamar et al., 1976; 
Mandybur et al., 1989). Several lines of evidence suggest these non-characterized, proteinous 
deposits are identical with the Reelin aggregates described here: 1) The description of their 
morphology and layer-specific accumulation in the hippocampal formation are in full 
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agreement with our observations. 2) In line with our findings, these deposits were found in 
close association with astrocytes. 3) Jucker and colleagues report a highly comparable time 
course of deposit formation with a peak at 18 month, a decline at 24 month, and high 
variability at 30 months, likely representing the few subjects with persistent high plaque load 
as described here. 4) We also share the observation that female mice are more affected than 
males. The immunohistochemical findings described by Jucker and colleagues included 
several extracellular matrix proteins, including Laminin B2, a 110 kDa Laminin-binding 
protein, as well as Heparin-sulfate-proteoglycan (Jucker et al., 1994b). Interestingly, 
proteolytic activity of Reelin on adhesion molecules of the extracellular matrix (including 
Laminin and Fibronectin) has been described (Quattrocchi et al., 2002). However, we failed to 
see any immunoreactivity of Laminin isoforms or Fibronectin within the Reelin plaques (data 
not shown). Since some of the antibodies might have labeled these structures non-specifically 
(M. Jucker, personal communication), further proteomic characterizations are needed to 
identify the exact composition of these aging-related extracellular Reelin deposits.  
No immunohistochemical evidence for co-localization of Reelin and Aβ plaques in AD 
has been provided, likely because of the selective association of Reelin with non-fibrillary 
plaques (Fig. 7). Altered expression and glycosylation patterns of Reelin in CSF and cortical 
extracts have been reported in AD (Botella-Lopez et al., 2006; Saez-Valero et al., 2003). A 
180-kDa Reelin fragment is preferentially up-regulated, while full-length and other forms 
remain unaltered in control and AD subjects (Botella-Lopez et al., 2006), indicating that the 
proteolytic processing alone cannot be responsible for these alterations. The different 
glycosylation pattern of the 180-kDa Reelin fragment in AD (Botella-Lopez et al., 2006) and 
our data obtained from 3xTg-AD mice suggest that the increase in Reelin in AD may be 
linked to its presence in soluble, non-fibrillary Aβ plaques. 
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The characterization of Reelin plaques in wild-type mice revealed accumulations of 
ApoER2 in potentially developing plaques, and the intracellular adaptor molecules Dab1 and 
Fe65 in large extracellular aggregates (Fig. 3), indicating that aging-induced Reelin reduction 
may provoke abnormal protein processing and degradation of downstream signaling proteins 
in wild-type mice. This hypothesis is supported by studies in transgenic animals showing 
ectopic accumulations of Dab1 in Reelin-, ApoER2-, and VLDLR-deficient mice (Rice and 
Curran, 2001; Trommsdorff et al., 1999). In-vitro studies showed that internalization of 
Reelin-ApoER2 complexes is required for endocytosis and proteasomal degradation of Dab1 
(Bock et al., 2004; D'Arcangelo et al., 1999). A direct role of Reelin in APP processing is 
demonstrated by the increased co-immunoprecipitation of Dab1 with ApoER2 and APP and 
decreased Aβ production (Hoe et al., 2006a), indicating that reduced Reelin levels might 
favor the production of neurotoxic Aβ species. 
Although we do not know yet whether the loss of Reelin-positive neurons is a direct cause 
or a consequence of the Reelin aggregates, several lines of evidence suggest that these two 
phenomena are related: Staining with the nuclear dye, Sytox green, and the microglial marker 
F4/80 revealed degenerating Reelin cells within plaques, as indicated by the condensed nuclei 
(Fig. 3). Plaque production decreased during aging after reduction of Reelin neurons in both 
mice and rats (Fig. 1, 4). SynGAP heterozygous knockout mice have fewer Reelin cells and 
develop fewer plaques than wild-type littermates (Fig. 5). These findings extend previous 
observations in mutant SynGAP mice showing increased neuronal apoptosis during late 
embryonic and early postnatal development (Knuesel et al., 2005). These mice also have 
reduced LTP and perform poorly in spatial memory tasks (Kim et al., 2003; Komiyama et al., 
2002), indicating that neurodevelopmental abnormalities affecting Reelin expression impair 
cognitive performance in adulthood.  
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The association of Reelin plaques with astroglia and activated microglia (Fig. 3) indicates 
activation of inflammatory processes. The observation of reduced plaque load in old mice and 
rats compared to ma wild-types (Fig. 1, 4, 5) suggests a beneficial immune response 
potentially limiting the progression of neurodegeneration. On the other hand, chronic 
activation of inflammatory pathways can be detrimental and promote degeneration, as 
suggested by increased expression of inflammatory mediators in postmortem AD tissue 
(Akiyama et al., 2000). However, it is unclear whether neuroinflammation represents a cause 
or consequence of ongoing disease processes. Based on genetic and epidemiological studies 
demonstrating a link between polymorphisms in cytokines and other immune molecules with 
AD, as well as the beneficial effect of anti-inflammatory drugs, respectively, inflammation 
has been considered a critical driving force of AD (for review, Wyss-Coray, 2006). We have 
recently demonstrated that prenatal immune challenge results in significant increases in fetal 
brain cytokine levels, including IL1β, IL6, IL10, and TNFα, neuromorphological alterations 
in juvenile and adult brains, and multiple behavioral abnormalities in the adult offspring, 
including cognitive deficits (Meyer et al., 2005; Meyer et al., 2006; Nyffeler et al., 2006). The 
findings presented here demonstrate that early manipulations of inflammatory pathways can 
change the course and severity of neurodegenerative processes in wild-type mice. In 
particular, prenatal PolyIC exposure provokes an earlier and much higher accumulation of 
Reelin plaques (Fig. 2, 6) and suggests that the long-term consequences of an early immune 
challenge favor the development of proteinous aggregates in the hippocampal formation of 
wild type mice. We also report accelerated loss of Reelin neurons following PolyIC exposure. 
Considering the moderate cell loss in ma mice, these findings suggest that the prenatal PolyIC 
exposure affects the survival of Reelin neurons in the postnatal brain, in line with our 
previous observation of a reduced Reelin-IR in the hippocampus of juvenile mice (Meyer et 
al., 2006). 
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A marked and prolonged increase in Reelin plaques number was found in 3xTg-AD mice 
(Fig. 7). These transgenic mice are characterized by early intraneuronal accumulation of Aβ, 
deficits in LTP and learning and memory before the formation of fibrillary plaques and 
tangles (Billings et al., 2005; Oddo et al., 2003). Immunotherapy results in clearance of 
intracellular Aβ and improvement in cognitive performance (Billings et al., 2005; Oddo et al., 
2004), implicating soluble/intraneuronal rather than fibrillary Aβ as causative factors of 
cognitive impairments. Although cognitive deficits persist or worsen, intraneuronal Aβ is 
relatively transient and declines with disease progression in humans and animal AD models 
(Wirths et al., 2004). The reduction in Reelin and concomitant accumulation in non-fibrillary 
Aβ plaques (Fig. 7 H, I) in 3xTg-AD mice reported here provides a probable explanation for 
the exacerbating memory impairments. Furthermore, the finding that Reelin co-localized with 
oligomeric Aβ species in the hippocampus but not in other brain areas (Fig. 7L) confirms the 
specificity of the immunostaining and indicates that Reelin itself forms oligomeric aggregates 
that are recognized by the A11 antibody. However, further biochemical evidence is needed to 
substantiate these findings. Interestingly, we also observed Reelin deposits that were 
surrounded by rodent-specific fibrillary Aβ plaques in 3xTg-AD mice (Fig. 7 J). Although we 
cannot rule out completely the possibility of human and rodent Aβ-specific antibody 
crosstalk, the observation of a partial co-localization of Reelin plaques with rodent Aβ in 
CON mice (Fig. 7 K) indicates that Reelin deposits may favor the development of fibrillary 
amyloid plaques. This hypothesis is in line with the novel role of Reelin in the adult brain 
which point to a critical involvement of this signaling pathway in the trafficking and 
processing of APP (Hoe et al., 2006a). On the other hand, is also conceivable that the 
overexpression of mutant human APP in the 3xTg-AD mice and the extracellular 
accumulation of Aβ peptides induces the aggregation of Reelin. Based on our findings in aged 
wild type rodents and marmoset monkeys we consider this scenario unlikely. However, we 
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cannot rule out that under these non-physiological conditions in transgenic mice, protein 
processing, degradation and clearance is likely severely impaired and may initiate a vicious 
cycle of extracellular protein aggregations involving both Reelin and Aβ peptides. 
In conclusion, our data revealed a strikingly consistent pattern of age-related loss of 
Reelin-expressing neurons and concomitant accumulation in extracellular amyloid-like 
plaques in the hippocampal formation (Fig. 8). We propose a model postulating that normal 
forms of aging involve successful elimination of plaques, whereas persons at-risk fail to do 
so. This hypothesis is supported by the outlier wild-type mice, characterized by unchanging 
high levels of Reelin plaques. Factors able to modulate course and magnitude of the plaque 
load include impaired immune responses and mutations favoring the production of toxic Aβ 
peptides. The reduced plaque number in animals with lower Reelin cell levels suggests a link 
between neuronal loss and plaque formation. Our results indicate that dysfunctional Reelin 
signaling may represent a causative factor in creating a precursor condition for senile plaque 
deposition in sporadic AD. 
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5. FIGURE LEGENDS 
Figure 1. Age-related episodic-like memory deficits coincide with accumulation of Reelin 
plaques in the hippocampal formation of wild-type mice. A) Design of the memory task on 
the radial arm maze consisting of repeated presentations of 3 pairs of arms. Food positions 
varied within each pair as a function of the preceding visit. Red arrow heads indicate the 
chosen arms during acquisition, blue arrow heads show the correct choices during test trials. 
RI = retention interval. B) Statistical analysis of the mean performance on the radial arm maze 
(RAM) task, expressed as % correct choices of the three different groups of wild-type mice 
across 12 days of training, yielded a significant effect of Age (F2,30 = 3.3, p < 0.05) and Blocks 
(F3,90 = 11.6, p < 0.001). The mean performance collapsed over days (middle graph) was 
significantly different between adult (ad, 72.0 ± 2.1%) and middle-aged (ma, 62.2 ± 4.2%; p = 
0.04) or old (61.7 ± 1.8%; p = 0.02) mice. Analysis of the mean performances using RI as 
within-subject factor yielded an Age x RI interaction (F8,120 = 2.0, p < 0.05) and a significant 
effect of RI (F4,120 = 23.6, p < 0.0001). ANOVA of the RI separately revealed a significant 
effect of Age for the RI = 1 (F2,30 = 3.7, p < 0.05) and RI = 2 (F2,30 = 4.0, p < 0.05). All values 
are given as mean ± SEM. *p < 0.05; **p < 0.01, statistical significance based on Fisher's 
LSD post hoc analysis. Dotted lines represent chance level. C–K) Reelin-immunoperoxidase 
(IP) staining of the dorsal (C–E) and ventral hippocampus (F–H) and entorhinal cortex (I-J) in 
coronal brain sections obtained from ad (3-mo; C, F, I), ma (12-mo; D, G, J-K), and old (24-
mo; E, H, L) wild-type mice. In ad mice, Reelin-immunoreactivity (IR) is evident in neuronal 
soma and the neuropil throughout the hippocampus and cortex. In ma and old mice, Reelin-IR 
is also found in plaque-like accumulations (arrows), restricted to the dorsal CA stratum oriens 
(so) and radiatum (sr) and outer DG molecular layer (ml). In the ventral hippocampus, they 
are strongly enriched in stratum lacunosum-moleculare (slm) and DG ml (arrows in D-H). 
Note the reduction in both Reelin neurons and plaques in old versus ma subjects. I, J) High 
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magnification pictures of the lateral entorhinal cortex (EC) of representative ad and ma mice. 
Reelin-IR was predominantly found in layer II and I. Age-related plaques are found 
exclusively in layer I. K, L) Plaques are found in close vicinity to Reelin neurons and are 
characterized by a granular rather than fibrillary appearance. Scale bars: E, F = 500 μm, I = 
50 μm, K, L = 20 μm. 
 
Figure 2. Neuronal loss and increase in plaque load contribute to the episodic-like memory 
deficits observed in aged wild-type mice. A) Statistical analysis of the number of Reelin-
expressing neurons revealed a significant Axis x Age interaction (F2, 30 = 4.3, p < 0.05), and 
significant main effects of Age (F2, 30 = 8.5, p < 0.01) and Axis (F1, 30 = 145.9, p < 0.001). The 
interaction reflects the more pronounced neuronal loss in ventral than in dorsal subfields of 
old compared to ma and ad mice. B) Similarly, statistical evaluations of the plaques yielded 
an Age x Axis interaction (F2,30 = 5.9, p < 0.01) and a significant effect of Axis (F1,30 = 50.9, p 
< 0.001). C) Group comparisons of the ratio of Reelin-positive cells/plaques in the dorsal and 
ventral hippocampus. D-E) Correlational analyses of the ratio cells/plaques and the mean 
performance in the memory task including RI = 1 & 2. Values are given as mean ± SEM. *p < 
0.05, **p < 0.01, statistical significance based on Fisher's LSD post hoc analysis. 
 
Figure 3. Reelin plaques are extracellular accumulations invaded by activated microglia and 
astrocytes. A–H) Representative high-magnification images of triple-immunofluorescence 
(IF) stainings of the ventral slm of 12-mo old wild-type mice using mouse anti-Reelin 
antibodies in combination with antibodies raised against markers of astrocytes (GFAP) and 
activated microglia (F4/80). Nuclei are counterstained with Sytox™ green. Note the close 
association of both astrocytes and activated microglia with Reelin plaques (D, H). Co-
localization of Reelin and F4/80 is evident within the plaque-like accumulations (arrowheads 
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in E, F, H).  Arrows and the inset in H point to condensed nuclei, invaded by activated 
microglia and likely representing degenerating Reelin-positive cells.  I-P) Members of the 
amyloid precursor protein signalling pathway are localized to Reelin-positive hippocampal 
plaques in wild-type mice. Representative images of double-IF stainings of the ventral 
hippocampus using mouse anti-Reelin and antibodies raised against the Reelin receptor 
ApoER2 (I-L), and the intracellular adaptor proteins Dab1 (M-N) and Fe65 (O–P). I) Reelin 
plaques differ in size and shape: the arrow points to large accumulations; arrowheads to 
smaller Reelin aggregates. J) Clusters of ApoER2 are in immediate contact with the Reelin-
plaques (green), predominantly with the smaller aggregates (inset in K is enlarged in L). M–
P) Immunostaining of the intracellular adaptors Dab1 and Fe65 in the hippocampus reveals 
extracellular accumulations highly co-localizing with the Reelin plaques (insets in N und P). 
Scale bars: A, E, M, O = 15 μm, I = 10 μm; L = 5 μm.  
 
Figure 4. Reelin plaques are found in aged Wistar rats and common marmoset monkeys.  
Low and high magnification images of coronal brain sections taken from 6- (A) and 20-mo 
(B–D) old rats, and 1- (G-H) and 10-year old monkeys (F) visualized with Reelin 
immunohistochemistry. A) No Reelin plaques are observed in 6-mo old rats. B-D) Reelin 
plaques and Reelin expressing cells with dystrophic neurites (arrows in C) are found in the 
hippocampus of 20-mo old rats. Note the loss of Reelin neurons in slm in the ventral 
hippocampus (arrows in B) of the 20-mo old subject. E) Schematic representation of the 
monkey hippocampus. F) Weak immunoreactivity of Reelin-expressing cells is evident in 10-
year old marmoset brain sections but large extracellular plaques are found in both sr and slm 
(arrows). G-H) Aggregated Reelin-IR is present both intracellularly and extracellularly on 
hippocampal brain sections of the 1-year old monkey. Scale bars: A = 200 μm; C, H = 20 μm; 
E = 500 μm; G = 10 μm. 
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Figure 5. Heterozygous SynGAP knockout (SG+/-) mice have less Reelin neurons and 
develop fewer plaques compared to littermate controls (SG+/+). A) Representative contours of 
the dorsal hippocampus of 3-mo old SG+/+ and SG+/- mice showing the lower numbers of 
Reelin-positive cells, particularly prominent in slm. B-C) Statistical evaluations of the number 
of Reelin-positive cells yielded a significant Subfields x Age interaction (F1,52 = 4.0, p < 0.05), 
confirming the higher age-related cell loss in CA than DG in both genotypes; as well as main 
effects of Genotype (F1,52 = 9.0, p < 0.01), Age (F2,52 = 8.6, p < 0.001), and Subfields (F1,52 = 
57.6, p < 0.001). D–F) Double IF stainings using anti-Reelin and anti-SynGAP antibodies on 
hippocampal brains sections of 12-mo old SG+/+ mice. SynGAP and Reelin are co-expressed 
in GABAergic interneurons (arrows). SynGAP IR is also found in large clusters; some in 
close association with Reelin plaques (arrowheads and inset in E). G-H) Reelin IP staining in 
12-mo old SG+/+ and SG+/- mice. Note the lower number of plaques in the ventral slm in SG+/- 
mice compared to SG+/+, paralleled by reduced numbers of Reelin-positive cells in so (arrows 
in G, H). J) Two year old SG+/+ mice have both fewer Reelin plaques and cells in so, sr and 
slm (arrows) as compared to 1-year old SG+/+ mice. K) A reduction of Reelin-positive cells is 
also evident in 2-year old SG+/- mice compared to the 1-year old subjects. Note the absence of 
plaques and reduced Reelin-immunoreactivity in the neuropil of the slm. Reelin plaques are 
mostly localized in the outer layer of the DG ml (arrowheads). I) Statistical evaluation of 
Reelin plaques in the dorsal and ventral hippocampus in SG+/+ and SG+/- mice revealed a Axis 
x Genotype interaction (F1,14 = 5.7, p < 0.05) and a main effect of Axis (F1,14 = 12.9, p < 0.01). 
L) Comparison of age-related plaque changes (averaged for dorsal and ventral) in SG+/+ and 
SG+/- mice. All values are given as mean ± SEM. +p = 0.05, *p < 0.05, **p < 0.01, #p < 0.05 
for genotype comparisons, statistical significance based on Fisher's LSD post hoc analysis. 
Scale bars: D = 30 μm, J = 200 μm.  
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Figure 6. Prenatal immune challenge results in earlier accumulations of Reelin plaques and 
loss of Reelin neurons. Representative images of coronal brain sections processed for Reelin 
immunohistochemistry taken from 6-mo old wild-type mice prenatally exposed to either 
vehicle (CON) or the synthetic viral mimic polyriboinosinic-polyribocytidilic acid (PolyIC), a 
synthetic analogue of double-stranded RNA. A-B) The IP labeling shows the early 
accumulation of plaques in the ventral slm (arrows) of PolyIC subjects while in CON only a 
few Reelin plaques are found at this age. C-D) Higher magnification of the DG shows the 
presence of Reelin plaques in the most outer region of the molecular layer. Note the 
concomitant reduction of Reelin-positive cells. E) Statistical analyses of the number of Reelin 
neurons yielded a significant Subfield x Treatment interaction (F1, 26 = 5.6, p = 0.025), 
reflecting the selective neuronal loss in CA in the PolyIC as compared to CON; and 
significant main effects of Axis and Subfield (both F1, 26 > 131, p < 0.0001). For the plaques, 
significant main effects of Treatment (F1, 26 = 5.03, p = 0.03) and Axis (F1, 26 = 12.1, p = 
0.002) were found. The ratio between Reelin-positive cells and plaques dropped significantly 
in PolyIC subjects compared to CON (p = 0.015). All values are given as mean ± SEM. *p < 
0.05; ***p < 0.001, statistical significance based on Fisher's LSD post hoc analysis. Scale 
bars: A = 500 μm, C = 50 μm, E = 20 μm. 
 
Figure 7. Reelin plaques are highly increased in Alzheimer’s disease mice and co-localize 
with non-fibrillary species of amyloid-β. Representative contours of the dorsal (upper 
drawings) and ventral (lower drawings) hippocampus of 15-mo old non-transgenic (CON) 
and triple-transgenic (3xTg-AD) mice. Red dots represent the individual Reelin plaques. C-I) 
Double IF staining of the dorsal CA1 sr of 3xTg-AD mice using anti-Reelin combined with 
anti-human Aβ and anti-Aβ oligomer species antibodies. C-E). Aβ-IR is present in both 
fibrillary plaques (arrow) and Reelin neurons. F–H) Aβ-IR is also present in Reelin plaques, 
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likely representing non-fibrillary forms of extracellular plaques, as supported by the co-
localization of Reelin with the A11 anti-Aβ oligomer-specific antibody (I). J) Rodent-specific 
fibrillary Aβ plaques (arrow) are also found in 3xTg-AD mice, preferentially localized around 
the Reelin plaques (enlarged view in inset). K) A selective association of Reelin- and Aβ-IR 
is also evident in CON wild type littermates. L) Single-labelled Aβ oligomer-specific deposits 
are found in neocortical layer I. M) Statistical evaluation of the Reelin plaques in the dorsal 
and ventral hippocampus of CON and 3xTg-AD mice revealed a main effect of Genotype (F1, 
16 = 7.4, p = 0.015) and Axis (F1, 16 = 24.6, p < 0.0001). Separate comparisons for the dorsal 
and ventral hippocampus yielded significant differences between CON and 3xTg-AD in the 
ventral (**p = 0.01), and a close to significant difference in the dorsal subfields (+p = 0.05, 
Fig. 7 L). Values are given as mean ± SEM. Scale bars: C, F, I = 10 μm, J, K, L = 20 μm.  
 
Figure 8. Comparison of the Reelin plaque load during normal aging (A), in animals with 
genetically induced neurodevelopmental abnormalities (B), following prenatal immune 
challenge (C), and neurodegenerative disorders (D). All values are displayed in box plot 
graphs. The dimensions of the box are defined by the 75th (top) and 25th percentile (bottom) 
and the median line. The upper and lower error bars indicate the 90th and 10th percentile, 
respectively. All observations above the 90th and below 10th percentile are represented as 
black dots. 
 
Supplementary Figure 1: Specificity control labelings. A-D) Representative images of the 
ventral hippocampus of a 12 months old wild type mouse stained with anti-Reelin antibody 
(A, C) or with the corresponding mouse IgG’s at the same concentration (1 μg/ml, B, D) and 
processed for immunoperoxidase labelings. Note the absence of any specific 
immunoreactivity using mouse IgG. Scale bars: B, 100 μm; D, 50 μm. 
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Table 1 Animals employed  
 
 
 
 
Group Species Strain Genotype Treatment Breeding Colony Age  Number Experiment  
1 Mice C57B6 Jico wild type none Janvier, Le 
Genest-Saint Isle, 
France 
4-5 mo 
11-14 mo 
20-23 mo 
7 ♂ 
10 ♂ 
16 ♂ 
Behavioural 
testing (RAM) 
Reelin-IHC: C/P 
2      
    
     
    
C57B6J SynGAP+/+ 
SynGAP+/- 
none ETH Zurich 3 mo 4 ♂, 3 ♀ 
6 mo 
12 mo 
24 mo 
 
6 ♀ 
4 ♂, 4 ♀  
8 ♂  
per genotype 
Reelin-IHC: C/P 
3 C57B6J wild type Prenatal PolyI:C or 
vehicle exposure 
ETH Zurich 
 
6 mo 10 ♂, 10 ♀ 
5 ♂, 5 ♀ 
Reelin-IHC: C/P 
4 129/C57B6J 3xTg-AD
non-Tg controls 
none ETH Zurich 15 mo 
 
8 ♂ 
10 ♂ 
Reelin-IHC: P 
5 Rats Wistar WIST:Hanlbm none
 
ETH Zurich 6 mo 
20 mo 
3 ♂ 
3 ♂ 
Reelin-IHC 
6    Monkeys Callithrix 
jacchus 
none ETH Zurich 1 y 
Anthropology 
University Zurich 
10 ys 
1 ♀ 
1 ♀ 
Reelin-IHC 
RAM = Radial arm maze task, IHC = Immunohistochemistry, C = Quantification of Reelin-pos neurons, P = Quantification of Reelin-pos plaques 
Table 2 List of antibodies 
 
 
 
 
IP, immunoperoxidase staining; IF, immunofluorescence staining 
Target protein Species Dilution Protocol Source Number 
Rodent Reelin (aa164-496, clone G10) Mouse 1:1000 IP/IF Chemicon International, Temecula, CA MAB5364 
Human ApoER2   Rabbit 1:500 IP/IF Santa Cruz Biotech. Inc., Santa Cruz, CA sc-20746 
Mouse Dab1  Rabbit 1:1000 IP/IF Chemicon International, Temecula, CA AB5840 
Mouse Fe65  Rabbit 1:1000 IP/IF Affinity BioReagents Inc., Golden, CO PA1-752 
Rat SynGAP  Rabbit 1:500 IF Affinity BioReagents Inc., Golden, CO PA1-046 
Cow GFAP Rabbit 1:5000 IF DakoCytomation, Glostrup, Denmark Z0334 
Mouse F4/80 (clone CI:A3-1) Rat 1:100 IF Abcam plc, Cambridge, UK ab6640 
Oligomer species (A11) Rabbit 1:50 IP/IF BioSource Intl. Inc., Camarillo, CA AHB0052 
Human β-amyloid (1-40/42) 
Human β-amyloid (1-17; clone 6E10) 
Rabbit 
Mouse 
1:500 
1:500 
IP/IF 
IP 
Chemicon International, Temecula, CA 
Chemicon International, Temecula, CA 
AB5076 
MAB1560 
Rodent β-amyloid (all isoforms) Rabbit 1:300 IP/IF Chemicon International, Temecula, CA AB5571 
Human Tau (phospho T205) Rabbit 1:2000 IP/IF Abcam plc, Cambridge, UK ab4841 
Mouse Laminin (all isoforms) Rabbit 1:5000 IF Chemicon International, Temecula, CA AB2034 
Mouse Fibronectin Rabbit 1:200 IF Chemicon International, Temecula, CA AB2033 
Table 2 List of antibodies 
 
 
 
 
Target protein Species Dilution Protocol Source Number 
Rodent Reelin (aa164-496, clone G10)    Mouse 1:1000 IP/IF Chemicon International, Temecula, CA MAB5364 
Human ApoER2   Rabbit 1:500 IP/IF Santa Cruz Biotech. Inc., Santa Cruz, CA sc-20746 
Mouse Dab1  Rabbit 1:1000 IP/IF Chemicon International, Temecula, CA AB5840 
Mouse Fe65  Rabbit 1:1000 IP/IF Affinity BioReagents Inc., Golden, CO PA1-752 
Rat SynGAP  Rabbit 1:500 IF Affinity BioReagents Inc., Golden, CO PA1-046 
Cow GFAP Rabbit 1:5000 IF DakoCytomation, Glostrup, Denmark Z0334 
Mouse F4/80 (clone CI:A3-1) Rat 1:100 IF Abcam plc, Cambridge, UK ab6640 
Oligomer species (A11) Rabbit 1:50 IP/IF BioSource Intl. Inc., Camarillo, CA AHB0052 
Human β-amyloid (1-40/42) 
Human β-amyloid (1-17; clone 6E10) 
Rabbit 
Mouse 
1:500 
1:500 
IP/IF 
IP 
Chemicon International, Temecula, CA 
 
AB5076 
MAB1560 
Rodent β-amyloid (all isoforms) Rabbit   1:300 IP/IF Chemicon International, Temecula, CA AB5571 
Human Tau (phospho T205) Rabbit 1:2000 IP/IF Abcam plc, Cambridge, UK ab4841 
Mouse Laminin (all isoforms) Rabbit 1:5000 IF Chemicon International, Temecula, CA AB2034 
Mouse Fibronectin Rabbit 1:200 IF Chemicon International, Temecula, CA AB2033 
IP, immunoperoxidase staining; IF, immunofluorescence staining 









